{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:57:09Z","timestamp":1782280629383,"version":"3.54.5"},"posted":{"date-parts":[[2025,7,18]]},"group-title":"Molecular Biology","reference-count":69,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease","doi-asserted-by":"crossref","award":["5F30AI164574-02"],"award-info":[{"award-number":["5F30AI164574-02"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Cancer Institute","award":["5R01CA201135"],"award-info":[{"award-number":["5R01CA201135"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,7,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Engineered plasma cells (ePCs) offer a durable strategy for in vivo delivery of therapeutic antibodies, but standard immunodeficient mouse models lack human immune factors critical for plasma cell survival and function. We utilized a humanized mouse model in which NOD.Cg-\n                  <jats:italic>Prkdc<\/jats:italic>\n                  <jats:sup>\n                    <jats:italic>scid<\/jats:italic>\n                  <\/jats:sup>\n                  <jats:italic>Il2rg<\/jats:italic>\n                  <jats:sup>\n                    <jats:italic>tm1Wjl<\/jats:italic>\n                  <\/jats:sup>\n                  \/SzJ (NSG) mice were engrafted with human CD34\n                  <jats:sup>+<\/jats:sup>\n                  stem cells as recipients for infusions with autologous ePCs. In this setting, ePCs localized to plasma cell niches and stably secreted antibodies for over three months. To improve the selection of antibodies for secretion, we developed a B cell receptor surface display screen that identified candidate antibody sequences with high secretion potential. An anti-SARS-CoV-2 antibody (clone 297) selected by this method showed robust secretion both in vitro and vivo, and serum from ePC-engrafted mice potently neutralized SARS-CoV-2 pseudovirus. Together, these findings establish a physiologically relevant model for testing human ePCs, and offer a generalizable strategy for optimizing antibody selection to support long-term therapeutic delivery.\n                <\/jats:p>","DOI":"10.1101\/2025.07.14.664835","type":"posted-content","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:21Z","timestamp":1752883221000},"source":"Crossref","is-referenced-by-count":0,"title":["Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic function"],"prefix":"10.64898","author":[{"given":"Tyler F.","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Helmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene Yu-Hong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah J.","family":"Homad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parnal","family":"Narvekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Asher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan D.","family":"Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma R.","family":"Suchland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andee R","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris D","family":"Thouvenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Stoffers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Lachkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Rawlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025072214550510000_2025.07.14.664835v1.1","doi-asserted-by":"crossref","first-page":"2040620719899897","DOI":"10.1177\/2040620719899897","article-title":"Management of toxicities associated with novel immunotherapy agents in acute lymphoblastic leukemia","volume":"11","year":"2020","journal-title":"Ther Adv Hematol"},{"key":"2025072214550510000_2025.07.14.664835v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00670-0"},{"issue":"5","key":"2025072214550510000_2025.07.14.664835v1.3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2217\/ijr.15.39","article-title":"Improving treatment adherence in patients with rheumatoid arthritis: what are the options?","volume":"10","year":"2015","journal-title":"Int J Clin Rheumtol"},{"key":"2025072214550510000_2025.07.14.664835v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/nature10660"},{"key":"2025072214550510000_2025.07.14.664835v1.5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.omtm.2017.09.003","article-title":"In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections","volume":"7","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2025072214550510000_2025.07.14.664835v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1967"},{"issue":"5","key":"2025072214550510000_2025.07.14.664835v1.7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa2410597","article-title":"Lentiviral gene therapy with CD34+ hematopoietic cells for hemophilia A","volume":"392","year":"2025","journal-title":"N Engl J Med"},{"key":"2025072214550510000_2025.07.14.664835v1.8","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42995"},{"issue":"1","key":"2025072214550510000_2025.07.14.664835v1.9","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1038\/s41467-020-19649-1","article-title":"Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion","volume":"11","year":"2020","journal-title":"Nat Commun"},{"key":"2025072214550510000_2025.07.14.664835v1.10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190287"},{"key":"2025072214550510000_2025.07.14.664835v1.11","unstructured":"Huang D , Tran JT , Olson A , et al. Vaccine Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells."},{"key":"2025072214550510000_2025.07.14.664835v1.12","doi-asserted-by":"crossref","unstructured":"Moffett HF , Harms CK , Fitzpatrick KS , Tooley MR , Boonyaratanakornkit J , Taylor JJ . B cells engineered to express pathogen-specific antibodies protect against infection. Sci Immunol. 2019;4(35).","DOI":"10.1126\/sciimmunol.aax0644"},{"issue":"11","key":"2025072214550510000_2025.07.14.664835v1.13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41419-020-03187-1","article-title":"Engineering of \u03b1-PD-1 antibody-expressing long-lived plasma cells by CRISPR\/Cas9-mediated targeted gene integration","volume":"11","year":"2020","journal-title":"Cell Death Dis"},{"key":"2025072214550510000_2025.07.14.664835v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/40540"},{"key":"2025072214550510000_2025.07.14.664835v1.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066092"},{"key":"2025072214550510000_2025.07.14.664835v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3964"},{"key":"2025072214550510000_2025.07.14.664835v1.17","doi-asserted-by":"publisher","DOI":"10.1038\/nri1886"},{"key":"2025072214550510000_2025.07.14.664835v1.18","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830160206"},{"issue":"1","key":"2025072214550510000_2025.07.14.664835v1.19","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1038\/s41467-022-33787-8","article-title":"Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo","volume":"13","year":"2022","journal-title":"Nat Commun"},{"key":"2025072214550510000_2025.07.14.664835v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.06.004"},{"issue":"6","key":"2025072214550510000_2025.07.14.664835v1.21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s41587-024-02283-3","article-title":"B cells as drug factories","volume":"42","year":"2024","journal-title":"Nat Biotechnol"},{"key":"2025072214550510000_2025.07.14.664835v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.11.012"},{"key":"2025072214550510000_2025.07.14.664835v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2009.06.005"},{"key":"2025072214550510000_2025.07.14.664835v1.24","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061508"},{"key":"2025072214550510000_2025.07.14.664835v1.25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112142"},{"issue":"Suppl 2","key":"2025072214550510000_2025.07.14.664835v1.26","first-page":"S155","article-title":"Humoral immunity in humanized mice: a work in progress","volume":"208 Suppl 2","year":"2013","journal-title":"J Infect Dis"},{"key":"2025072214550510000_2025.07.14.664835v1.27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318025"},{"key":"2025072214550510000_2025.07.14.664835v1.28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-02-832089"},{"key":"2025072214550510000_2025.07.14.664835v1.29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031330"},{"key":"2025072214550510000_2025.07.14.664835v1.30","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.61"},{"key":"2025072214550510000_2025.07.14.664835v1.31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.12.7867"},{"key":"2025072214550510000_2025.07.14.664835v1.32","doi-asserted-by":"crossref","unstructured":"Moens L , Tangye SG . Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage. Front Immunol. 2014;5:65.","DOI":"10.3389\/fimmu.2014.00065"},{"key":"2025072214550510000_2025.07.14.664835v1.33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.10.6477"},{"key":"2025072214550510000_2025.07.14.664835v1.34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209034"},{"key":"2025072214550510000_2025.07.14.664835v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.026"},{"issue":"5","key":"2025072214550510000_2025.07.14.664835v1.36","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1182\/blood.V69.5.1307.1307","article-title":"The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor","volume":"69","year":"1987","journal-title":"Blood"},{"issue":"742","key":"2025072214550510000_2025.07.14.664835v1.37","doi-asserted-by":"crossref","first-page":"eadh8846","DOI":"10.1126\/scitranslmed.adh8846","article-title":"BCR signaling is required for posttransplant lymphoproliferative disease in immunodeficient mice receiving human B cells","volume":"16","year":"2024","journal-title":"Sci Transl Med"},{"key":"2025072214550510000_2025.07.14.664835v1.38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220849"},{"key":"2025072214550510000_2025.07.14.664835v1.39","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444729"},{"key":"2025072214550510000_2025.07.14.664835v1.40","doi-asserted-by":"crossref","unstructured":"David M , Monteferrario D , Saviane G , et al. Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium. Mol Ther Methods Clin Dev. 2023;31:101111.","DOI":"10.1016\/j.omtm.2023.101111"},{"key":"2025072214550510000_2025.07.14.664835v1.41","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12011"},{"key":"2025072214550510000_2025.07.14.664835v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80541-5"},{"key":"2025072214550510000_2025.07.14.664835v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.04.015"},{"key":"2025072214550510000_2025.07.14.664835v1.44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221717"},{"key":"2025072214550510000_2025.07.14.664835v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2012.01.006"},{"key":"2025072214550510000_2025.07.14.664835v1.46","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095921"},{"key":"2025072214550510000_2025.07.14.664835v1.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.12.042"},{"key":"2025072214550510000_2025.07.14.664835v1.48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.081828"},{"key":"2025072214550510000_2025.07.14.664835v1.49","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000619"},{"key":"2025072214550510000_2025.07.14.664835v1.50","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-0977"},{"key":"2025072214550510000_2025.07.14.664835v1.51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200356"},{"key":"2025072214550510000_2025.07.14.664835v1.52","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0998"},{"key":"2025072214550510000_2025.07.14.664835v1.53","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200045R"},{"key":"2025072214550510000_2025.07.14.664835v1.54","doi-asserted-by":"publisher","DOI":"10.3390\/v15020365"},{"key":"2025072214550510000_2025.07.14.664835v1.55","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101667"},{"key":"2025072214550510000_2025.07.14.664835v1.56","doi-asserted-by":"publisher","DOI":"10.2337\/diab.42.11.1574"},{"key":"2025072214550510000_2025.07.14.664835v1.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2017.03.021"},{"key":"2025072214550510000_2025.07.14.664835v1.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.06.001"},{"key":"2025072214550510000_2025.07.14.664835v1.59","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01880-3"},{"key":"2025072214550510000_2025.07.14.664835v1.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2009.05.019"},{"key":"2025072214550510000_2025.07.14.664835v1.61","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.104.3.761"},{"issue":"2","key":"2025072214550510000_2025.07.14.664835v1.62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4161\/mabs.23392","article-title":"Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression","volume":"5","year":"2013","journal-title":"MAbs"},{"key":"2025072214550510000_2025.07.14.664835v1.63","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzs042"},{"key":"2025072214550510000_2025.07.14.664835v1.64","doi-asserted-by":"publisher","DOI":"10.1126\/science.adi1763"},{"key":"2025072214550510000_2025.07.14.664835v1.65","doi-asserted-by":"publisher","DOI":"10.1101\/2022.08.25.505190"},{"key":"2025072214550510000_2025.07.14.664835v1.66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000583"},{"key":"2025072214550510000_2025.07.14.664835v1.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.11.029"},{"key":"2025072214550510000_2025.07.14.664835v1.68","doi-asserted-by":"publisher","DOI":"10.7717\/PEERJ.14041\/SUPP-11"},{"key":"2025072214550510000_2025.07.14.664835v1.69","doi-asserted-by":"publisher","DOI":"10.3390\/v12050513"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.07.14.664835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:04:48Z","timestamp":1782277488000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.07.14.664835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":69,"URL":"https:\/\/doi.org\/10.1101\/2025.07.14.664835","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1016\/j.omta.2026.201666","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,7,18]]},"subtype":"preprint"}}